Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02498990
What this trial is testing

Low Calorie Diet and Diabetes

Who this might be right for
Diabetes Mellitus Type 2DyslipidemiaNon-alcoholic Fatty Liver Disease+1 more
Karolinska University Hospital 40
Not applicableEnded earlyNCT01200082
What this trial is testing

Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases

Who this might be right for
Hepatobiliary Diseases
University of Nebraska 430
Early research (Phase 1)Study completedNCT04083716
What this trial is testing

Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 15
Not applicableUnknownNCT04443049
What this trial is testing

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Institute of Liver and Biliary Sciences, India 170
Early research (Phase 1)Not Yet RecruitingNCT06661148
What this trial is testing

Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BHBV (Hepatitis B Virus)
Epigenic Therapeutics, Inc 36
Testing effectiveness (Phase 2)Study completedNCT06247735
What this trial is testing

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

Who this might be right for
Primary Biliary Cholangitis
Kowa Research Institute, Inc. 46
Not applicableUnknownNCT05968378
What this trial is testing

Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver FatObesity+1 more
University College Dublin 60
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Not applicableStudy completedNCT01767597
What this trial is testing

Application of HBV Rapid Tests as a Tool for Wide-Use Screening

Who this might be right for
Hepatitis BLiver CirrhosisCarcinoma, Hepatocellular
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 1,000
Testing effectiveness (Phase 2)Study completedNCT01188733
What this trial is testing

Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionEsophageal Varices
Mayo Clinic 39
Not applicableStudy completedNCT02932449
What this trial is testing

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Who this might be right for
Biliary Cirrhosis, Primary
Target PharmaSolutions, Inc. 711
Not applicableActive Not RecruitingNCT06854185
What this trial is testing

Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseOverweight (BMI > 25)Metabolic Syndrome
Baylor College of Medicine 50
Not applicableEnded earlyNCT02503735
What this trial is testing

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

Who this might be right for
Hepatitis CChronic Kidney Disease
Massachusetts General Hospital 14
Not applicableStudy completedNCT02880189
What this trial is testing

EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity

Who this might be right for
ObesityNon-Alcoholic Steatohepatitis
Mayo Clinic 21
Very early researchStudy completedNCT03253276
What this trial is testing

Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT

Who this might be right for
Primary Biliary Cirrhosis
University of Aarhus 8
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableStudy completedNCT07811713
What this trial is testing

Effect of LSD on Renal Function in Cirrhotic Patients With Portal Hypertension

Who this might be right for
Cirrhosis, LiverSplenectomy; StatusRenal Function Abnormal+1 more
Northern Jiangsu People's Hospital 496
Large-scale testing (Phase 3)Study completedNCT01088659
What this trial is testing

Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 50
Not applicableStudy completedNCT04994548
What this trial is testing

Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension

Who this might be right for
Esophageal NeoplasmsCirrhosisPortal Hypertension
Central Hospital, Nancy, France 112
Not applicableStudy completedNCT02201797
What this trial is testing

Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

Who this might be right for
Metastatic Liver Cancer
Asan Medical Center 13
Next Page